Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.
J Antimicrob Chemother
; 74(2): 473-479, 2019 02 01.
Article
in En
| MEDLINE
| ID: mdl-30380053
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
HIV Integrase Inhibitors
/
Anti-HIV Agents
/
Drug Resistance, Viral
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Africa
Language:
En
Journal:
J Antimicrob Chemother
Year:
2019
Type:
Article
Affiliation country:
South Africa